Hansen Carl L. G.

CIK 00018344121 companyVANCOUVER, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001834412

Recent Transactions

36 trades

Award
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2026-01-01+2,106,505→ 13,096,837 total
Award
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2025-01-01+2,730,109→ 10,990,332 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2024-11-25−56,125→ 8,260,223 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2024-11-25$2.70/sh+56,125→ 898,000 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2024-09-20−56,125→ 8,316,348 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2024-09-20$2.70/sh+56,125→ 841,875 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2024-05-31−56,125→ 8,372,473 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2024-05-31$2.70/sh+56,125→ 785,750 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2024-02-26−56,125→ 8,428,598 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2024-02-26$2.70/sh+56,125→ 729,625 total
Award
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2024-01-14+2,095,532→ 8,484,723 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2023-11-23−56,125→ 6,389,191 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2023-11-23$2.70/sh+56,125→ 673,500 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2023-08-24$2.70/sh+56,125→ 617,375 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2023-08-24−56,125→ 6,445,316 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2023-05-26$2.70/sh+56,125→ 561,250 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2023-05-26−56,125→ 6,501,441 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2023-02-22−56,125→ 6,557,566 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2023-02-22$2.70/sh+56,125→ 505,125 total
Award
AbCellera Biologics Inc.$ABCL
Share Options (right to buy)
2022-12-01+925,069→ 6,613,691 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2022-11-18$2.70/sh+56,125→ 449,000 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2022-11-18−56,125→ 5,688,622 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2022-08-18−56,125→ 5,744,747 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2022-08-18$2.70/sh+56,125→ 392,875 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2022-05-18−56,125→ 5,800,872 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2022-05-18$2.70/sh+56,125→ 336,750 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2022-02-22$2.70/sh+56,125→ 280,625 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2022-02-22−56,125→ 5,856,997 total
Award
AbCellera Biologics Inc.$ABCL
Share Option (right to buy)
2021-12-07+920,312→ 5,913,122 total
Gift
AbCellera Biologics Inc.$ABCL
Common Shares
2021-12-07−750,000→ 53,807,290 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2021-11-18−224,500→ 4,992,810 total
Exercise/Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2021-11-18$15.03/sh+224,500→ 224,500 total
Sale
AbCellera Biologics Inc.$ABCL
Common Shares
2021-06-09$24.03/sh−5,598,420→ 55,604,330 total
Sale
AbCellera Biologics Inc.$ABCL
Common Shares
2021-06-09$25.50/sh−401,580→ 233,500 total
Gift
AbCellera Biologics Inc.$ABCL
Common Shares
2021-05-24−1,250,000→ 54,557,290 total
Gift
AbCellera Biologics Inc.$ABCL
Common Shares
2021-05-24−223,500→ 0 total

Companies

AbCellera Biologics Inc.
Director, Chief Executive Officer, 10% Owner
$ABCL

Recent Filings

Address

C/O ABCELLERA BIOLOGICS INC 150 W 4TH AVENUE

VANCOUVER, A1

View on SEC.gov